Search
Aspartic acid
go.drugbank.com/drugs/DB00128ApprovedInvestigationalNutraceuticalOne of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
Mixtures: Aminosyn II 7% M In 10% Dextrose(dual Chamber), Aminosyn II in DextroseSynonyms: D, (S)-2-aminosuccinic acidSilicon
go.drugbank.com/drugs/DB12982ApprovedSilicon is under investigation in clinical trial NCT00103246 (Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or … Stage II Mycosis Fungoides).
Mixtures: Calcium With Mg Zn Mn Cu CR Si and Vit. C & D, Procosa IICetylpyridinium
go.drugbank.com/drugs/DB11073ApprovedInvestigationalCetylpyridinium is a quaternary ammonium with broad-spectrum antiseptic properties. … In these products, it generally mediates an antiseptic activity and protective action against dental plaque and reducing gingivitis.
Synonyms: 1-hexadecylpyridiniumMixtures: BUCOSEPTOL N, NORAVER P TABLETAS DE DISOLUCIÓN BUCALLymphoma, Diffuse
go.drugbank.com/conditions/DBCOND0036855Synonyms: Non-Hodgkin lymphoma, no ICD-O subtype, Non-Hodgkin lymphoma, no ICD-O subtype (morphologic abnormality)Non-Hodgkin's Lymphoma (NHL)
go.drugbank.com/conditions/DBCOND0030854Synonyms: Non-Hodgkin lymphoma, no ICD-O subtype, Non-Hodgkin lymphoma, no ICD-O subtype (morphologic abnormality)Macitentan
go.drugbank.com/drugs/DB08932ApprovedInvestigationalA combination product (Opsynvi) comprising macitentan and [tadalafil] was approved in Canada in October 2021 for the treatment of PAH.[L39105] It was subsequently approved by the FDA in March 2024. … Macitentan is a dual endothelin receptor antagonist used in the treatment of pulmonary arterial hypertension (PAH).[L35890] It was first approved by the FDA in 2013.
Mixtures: OPSYNVI® (MACITENTAN/TADALAFILO) 10MG/40 MG TABLETAS RECUBIERTASCategories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 1-RingInactive phospholipase C-like protein 1
go.drugbank.com/bio_entities/BE0001081TargetHumansComponent in the phospho-dependent endocytosis process of GABA A receptor (By similarity). … Involved in an inositol phospholipid-based intracellular signaling cascade. Shows no PLC activity to phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol.
Synonyms: Phospholipase C-deleted in lung carcinomaGremlin-1
go.drugbank.com/bio_entities/BE0011799TargetHumansDown-regulates the BMP4 signaling in a dose-dependent manner (By similarity). Antagonist of BMP2; inhibits BMP2-mediated differentiation of osteoblasts (in vitro) (PubMed:27036124). … Cytokine that may play an important role during carcinogenesis and metanephric kidney organogenesis, as a BMP antagonist required for early limb outgrowth and patterning in maintaining the FGF4-SHH feedback
Synonyms: Increased in high glucose protein 2, Down-regulated in Mos-transformed cells protein1-acyl-sn-glycerol-3-phosphate acyltransferase beta
go.drugbank.com/bio_entities/BE0011578TargetHumansConverts 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid or LPA) into 1,2-diacyl-sn-glycerol-3-phosphate (phosphatidic acid or PA) by incorporating an acyl moiety at the sn-2 position of the glycerol backbone
Synonyms: 1-acylglycerol-3-phosphate O-acyltransferase 2Function: 1-acylglycerol-3-phosphate O-acyltransferase activityGlabellar Frown Lines (GL)
go.drugbank.com/conditions/DBCOND0081153Drugs: Botulinum toxin type ASynonyms: Glabellar Lines, Glabellar Frown Lines